China NT Pharma Group Company Limited
HKEX:1011.HK
0.335 (HKD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q4 | 2024 Q2 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q2 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | 2012 Q2 | 2011 Q4 | 2011 Q2 | 2010 Q4 | 2010 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.663 | 31.297 | 7.366 | 86.591 | 120.501 | 115.466 | 111.233 | 89.436 | 94.023 | 0 | 311.985 | 0 | 314.399 | 0 | 385.789 | 466.823 | 380.903 | 456.522 | 408.099 | 227.851 | 526.264 | 369.566 | 369.566 | 1,379.071 | 1,379.071 | 1,333.989 | 1,333.989 |
| Cost of Revenue
| 7.109 | 25.591 | 30.306 | 36.176 | 45.63 | 41.668 | 39.572 | 32.738 | 32.786 | 0 | 70.844 | 0 | 85.325 | 0 | 229.046 | 195.519 | 200.7 | 229.69 | 243.59 | 129.526 | 335.621 | 233.657 | 233.657 | 933.748 | 933.748 | 1,002.388 | 1,002.388 |
| Gross Profit
| -0.446 | 5.706 | -22.94 | 50.415 | 74.871 | 73.798 | 71.661 | 56.698 | 61.237 | 0 | 241.141 | 0 | 229.074 | 0 | 156.743 | 271.304 | 180.203 | 226.832 | 164.509 | 98.325 | 190.643 | 135.91 | 135.91 | 445.323 | 445.323 | 331.602 | 331.602 |
| Gross Profit Ratio
| -0.067 | 0.182 | -3.114 | 0.582 | 0.621 | 0.639 | 0.644 | 0.634 | 0.651 | 0 | 0.773 | 0 | 0.729 | 0 | 0.406 | 0.581 | 0.473 | 0.497 | 0.403 | 0.432 | 0.362 | 0.368 | 0.368 | 0.323 | 0.323 | 0.249 | 0.249 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 3.762 | 0 | 5.959 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.477 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 11.441 | 7.045 | 10.109 | 33.547 | 26.331 | 43.156 | 36.175 | 44.403 | 37.981 | 0 | 51.693 | 0 | 50.309 | 0 | 28.464 | 66.123 | 24.531 | 46.221 | 26.877 | 67.48 | 45.231 | 64.649 | 64.649 | 64.541 | 64.541 | 45.028 | 45.028 |
| Selling & Marketing Expenses
| 0.055 | 0.055 | 11.039 | 2.51 | 48.749 | 97.422 | 52.441 | 38.426 | 41.048 | 0 | 50.043 | 0 | 46.225 | 0 | 72.939 | 138.97 | 89.929 | 138.857 | 125.726 | 135.291 | 240.516 | 289.913 | 289.913 | 226.417 | 226.417 | 177.228 | 177.228 |
| SG&A
| 11.386 | 7.1 | 10.109 | 31.288 | 75.08 | 150.317 | 88.616 | 82.829 | 79.029 | 0 | 101.77 | 0 | 96.996 | 0 | 102.799 | 220.91 | 119.635 | 164.357 | 152.603 | 181.275 | 285.747 | 354.562 | 354.562 | 290.958 | 290.958 | 222.256 | 222.256 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.112 | 0.112 | -28.411 | -28.411 | -18.423 | -18.423 |
| Operating Expenses
| 11.386 | 7.1 | 10.109 | 40.577 | 67.295 | 162.164 | 43.559 | 79.15 | 85.374 | 0 | 99.854 | 0 | 88.158 | 0 | 98.64 | 205.878 | 124.004 | 181.994 | 135.047 | 268.895 | 624.556 | 353.499 | 353.499 | 262.547 | 262.547 | 203.833 | 203.833 |
| Operating Income
| -11.832 | -1.394 | -2.743 | 19.154 | -0.236 | -76.665 | -16.809 | -24.664 | -22.242 | 0 | 138.719 | 0 | 141.604 | 0 | 57.89 | 76.858 | 60.616 | 44.05 | 34.439 | -80.195 | -94.567 | -558.595 | -558.595 | 182.776 | 182.776 | 127.769 | 127.769 |
| Operating Income Ratio
| -1.776 | -0.045 | -0.372 | 0.221 | -0.002 | -0.664 | -0.151 | -0.276 | -0.237 | 0 | 0.445 | 0 | 0.45 | 0 | 0.15 | 0.165 | 0.159 | 0.096 | 0.084 | -0.352 | -0.18 | -1.511 | -1.511 | 0.133 | 0.133 | 0.096 | 0.096 |
| Total Other Income Expenses Net
| -42.433 | 2.179 | -2.053 | -46.161 | -34.872 | -68.493 | -31.904 | -27.047 | -22.185 | 0 | -26.29 | 0 | -29.583 | 0 | -8.014 | -16.232 | -19.02 | -42.344 | -36.4 | -111.125 | -366.954 | -30.049 | -30.049 | -29.042 | -29.042 | -22.69 | -22.69 |
| Income Before Tax
| -54.265 | 0.785 | -4.796 | -27.007 | -27.289 | -145.158 | -3.594 | -48.499 | -44.427 | 0 | 116.194 | 0 | 111.402 | 0 | 54.034 | 62.544 | 38.161 | 14.182 | 3.145 | -191.32 | -461.521 | -588.644 | -588.644 | 153.735 | 153.735 | 105.079 | 105.079 |
| Income Before Tax Ratio
| -8.144 | 0.025 | -0.651 | -0.312 | -0.226 | -1.257 | -0.032 | -0.542 | -0.473 | 0 | 0.372 | 0 | 0.354 | 0 | 0.14 | 0.134 | 0.1 | 0.031 | 0.008 | -0.84 | -0.877 | -1.593 | -1.593 | 0.111 | 0.111 | 0.079 | 0.079 |
| Income Tax Expense
| 0.247 | 0.124 | 0.816 | 11.16 | 0.949 | 2.582 | -0.94 | -1.754 | 0.05 | 0 | 10.297 | 0 | 9.013 | 0 | 3.966 | 11.34 | 1.671 | 14.389 | 0.851 | 50.052 | 29.435 | -33.986 | -33.986 | 36.546 | 36.546 | 40.374 | 40.374 |
| Net Income
| -54.018 | 0.661 | -5.612 | -38.167 | -28.238 | -146.884 | -2.654 | -46.745 | -43.426 | 0 | 104.508 | 0 | 102.884 | 0 | 50.068 | 51.204 | 36.49 | -0.207 | 2.294 | -241.372 | -432.086 | -554.658 | -554.658 | 117.189 | 117.189 | 64.305 | 64.305 |
| Net Income Ratio
| -8.107 | 0.021 | -0.762 | -0.441 | -0.234 | -1.272 | -0.024 | -0.523 | -0.462 | 0 | 0.335 | 0 | 0.327 | 0 | 0.13 | 0.11 | 0.096 | -0 | 0.006 | -1.059 | -0.821 | -1.501 | -1.501 | 0.085 | 0.085 | 0.048 | 0.048 |
| EPS
| -0.2 | 0 | -0.003 | -0.02 | -0.015 | -0.078 | -0.001 | -0.025 | -0.026 | 0 | 0.056 | 0 | 0.065 | 0 | 0.032 | 0.033 | 0.028 | -0 | 0.002 | -0.22 | -0.4 | -0.51 | -0.51 | 0.12 | 0.12 | 0.08 | 0.08 |
| EPS Diluted
| -0.2 | 0 | -0.003 | -0.02 | -0.015 | -0.078 | -0.001 | -0.025 | -0.026 | 0 | 0.056 | 0 | 0.065 | 0 | 0.032 | 0.033 | 0.028 | -0 | 0.002 | -0.22 | -0.4 | -0.51 | -0.51 | 0.12 | 0.12 | 0.08 | 0.08 |
| EBITDA
| -7.263 | -1.387 | -2.56 | 26.493 | 9.582 | -54.342 | -2.928 | -14.472 | -13.647 | 0 | 149.677 | 0 | 150.24 | 0 | 67.594 | 84.211 | 68.38 | 58.863 | 46.721 | -65.79 | 0 | -548.723 | -548.723 | 194.898 | 194.898 | 136.481 | 136.481 |
| EBITDA Ratio
| -1.09 | -0.044 | -0.348 | 0.306 | 0.08 | -0.471 | -0.026 | -0.162 | -0.145 | 0 | 0.48 | 0 | 0.478 | 0 | 0.175 | 0.18 | 0.18 | 0.129 | 0.114 | -0.289 | 0 | -1.485 | -1.485 | 0.141 | 0.141 | 0.102 | 0.102 |